Reasons and method to prevent, when possible, atrial fibrillation
Keywords:
atrial fibrillation, disease preventionDownloads
References
1. García-Cosío F. ¿Hacia dónde se dirige la investi-gación sobre fibrilación auricular? Rev Esp Cardiol. 2000;53:1318-24.
2. Merino JL, Doiny D, Estrada A, Castrejon S, Filguei-ras D, Ortega M, et al. Repercusión de la fibrilación auricular: Epidemiología e impacto clínico-eco-nómico. [Internet]. 2011 [citado 9 Oct 2011];1 (2):[aprox. 13 p.]. Disponible en: http://www.ria-online.com/webapp/journal/show/id/RIA10149
3. Curtis AB. Update on the clinical management of atrial fibrillation: guidelines and beyond. Postgrad Med. 2011;123(6):7-20.
4. Chávez González E. ¿Por qué no mirar a la Fibri-lación Auricular cuando es prevenible? RIA [Internet]. 2011 [citado 9 Oct 2011];1(2):[aprox. 13 p.]. Disponible en: http://www.ria-online.com/webapp/journal/show/id/RIA10150
5. Moro Serrano C, Hernández–Madrid A. Fibrilación auricular: ¿estamos ante una epidemia? Rev Esp Cardiol. 2009;62(1):10-4.
6. Pandit SV, Jalife J. Aging and atrial fibrillation research: where we are and where we should go. Heart Rhythm. 2007;4(2):186-7.
7. European Heart Rhythm Association; Heart Rhythm Society, Fuster V, Rydén LE, Cannom DS, Crijns HJ, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:854-906.
8. Uribe Arango W. Rompiendo el Paradigma “La redefinición de las metas terapéuticas en FA”. RIA [Internet]. 2011 [citado 9 Oct 2011]:[aprox. 46 p.]. Disponible en: http://www.ria-online.com/webapp/journal/show/id/RIA10143
9. Jalife J. ¿Por qué es la aurícula izquierda tan impor-tante en el mecanismo de la fibrilación auricular crónica? RIA [Internet]. 2009 [citado 9 Oct 2009]; 1(1):[aprox. 24p]. Disponible en: http://www.ria-online.com/webapp/journal/show/id/RIA1015
10. Chávez González E. Del impulso eléctrico auricular heterogéneo a la fibrilación auricular. ¿cómo pre-verla en el electrocardiograma? Avances Cardiol. 2011;31(3):247-53.
11. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. JACC. 2005;45(11):1832-9.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2012 CorSalud

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.





